Label: TRIAMCINOLONE ACETONIDE- triamcinolone acetonide ointment usp, 0.05% ointment
- NDC Code(s): 21922-024-11
- Packager: Encube Ethicals Private Limited
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated January 5, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
DESCRIPTIONThe topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. The steroids in this class include triamcinolone acetonide ...
-
CLINICAL PHARMACOLOGYTopical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various ...
-
INDICATIONS AND USAGETriamcinolone Acetonide Ointment 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
-
CONTRAINDICATIONSTopical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.
-
PRECAUTIONSGeneral - Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and ...
-
ADVERSE REACTIONSThe following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings (reactions are listed in an ...
-
OVERDOSAGETopically applied corticosteroids can be absorbed in sufficient amounts to produce systemic effects (see PRECAUTIONS, General).
-
DOSAGE AND ADMINISTRATIONApply a thin film of Triamcinolone Acetonide Ointment 0.05% to the affected area two to four times daily. Occlusive Dressing Technique - Occlusive dressings may be used for the management of ...
-
HOW SUPPLIEDTriamcinolone Acetonide Ointment USP, 0.05%: jar containing 430 g (NDC 21922-024-11) KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. You may report Side effects to FDA at ...
-
PACKAGE LABEL.PRINCIPAL DISPLAY PANELPRINCIPAL DISPLAY PANEL - 430 g Jar - NDC 21922-024-11 - Triamcinolone Acetonide Ointment USP, 0.05% Rx Only - 430 g
-
INGREDIENTS AND APPEARANCEProduct Information